{"DataElement":{"publicId":"6572596","version":"1","preferredName":"Differentiated Thyroid Cancer AJCC Edition 8 Clinical Tumor T Category","preferredDefinition":"Extent of the primary differentiated thyroid carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"DTC_AJC8_CLN_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6572578","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Clinical T Category","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3461579v1.0:2207100v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3461579","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)","longName":"C7153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Differentiated Thyroid Gland Carcinoma","conceptCode":"C7153","definition":"An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02DD092-1787-CCAB-E040-BB89AD430207","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"ONEDATA","dateModified":"2012-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD3952E-63C8-3CFA-E053-F662850A46AB","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6572265","version":"1","preferredName":"Differentiated and Anaplastic Thyroid Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic (undifferentiated) thyroid carcinoma, following the rules of the TNM AJCC v8 classification system. Medullary thyroid cancers are staged according to the classification for thyroid-medullary. Thyroid lymphomas are staged according to the classification for Hodgkin and non-Hodgkin lymphoma. There are no AJCC staging systems for thyroid cancer arising from thyroglossal duct cyst and thyroid cancer in malignant struma ovarii. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6572265v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4b TNM Finding v8","ValueMeaning":{"publicId":"6572267","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4b TNM Finding v8","longName":"6572267","preferredDefinition":"Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4b TNM Finding v8","conceptCode":"C140924","definition":"Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BCE8-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BD01-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4a TNM Finding v8","ValueMeaning":{"publicId":"6572269","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4a TNM Finding v8","longName":"6572269","preferredDefinition":"Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4a TNM Finding v8","conceptCode":"C140923","definition":"Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BD0E-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BD27-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T4","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4 TNM Finding v8","ValueMeaning":{"publicId":"6572271","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4 TNM Finding v8","longName":"6572271","preferredDefinition":"Tumor of any size with gross extrathyroidal extension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT4 TNM Finding v8","conceptCode":"C140922","definition":"Tumor of any size with gross extrathyroidal extension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BD34-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BD4D-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3b TNM Finding v8","ValueMeaning":{"publicId":"6572273","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3b TNM Finding v8","longName":"6572273","preferredDefinition":"Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3b TNM Finding v8","conceptCode":"C140921","definition":"Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BD5A-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BD73-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3a TNM Finding v8","ValueMeaning":{"publicId":"6572275","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3a TNM Finding v8","longName":"6572275","preferredDefinition":"Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3a TNM Finding v8","conceptCode":"C140920","definition":"Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BD80-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BD99-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T3","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3 TNM Finding v8","ValueMeaning":{"publicId":"6572277","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3 TNM Finding v8","longName":"6572277","preferredDefinition":"Tumor measuring more than 4 cm in greatest dimension limited to the thyroid, or gross extrathyroidal extension invading only strap muscles. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT3 TNM Finding v8","conceptCode":"C140919","definition":"Tumor measuring more than 4 cm in greatest dimension limited to the thyroid, or gross extrathyroidal extension invading only strap muscles. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BDA6-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BDBF-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT2 TNM Finding v8","ValueMeaning":{"publicId":"6572304","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT2 TNM Finding v8","longName":"6572304","preferredDefinition":"Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT2 TNM Finding v8","conceptCode":"C140918","definition":"Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BDCC-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BDE5-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1b TNM Finding v8","ValueMeaning":{"publicId":"6572306","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1b TNM Finding v8","longName":"6572306","preferredDefinition":"Tumor measuring more than 1 cm but 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1b TNM Finding v8","conceptCode":"C140917","definition":"Tumor measuring more than 1 cm but 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BDF2-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BE0B-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1a TNM Finding v8","ValueMeaning":{"publicId":"6572308","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1a TNM Finding v8","longName":"6572308","preferredDefinition":"Tumor measuring 1 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1a TNM Finding v8","conceptCode":"C140916","definition":"Tumor measuring 1 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BE18-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BE31-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1 TNM Finding v8","ValueMeaning":{"publicId":"6572310","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1 TNM Finding v8","longName":"6572310","preferredDefinition":"Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT1 TNM Finding v8","conceptCode":"C140915","definition":"Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BE3E-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BE57-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"T0","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT0 TNM Finding v8","ValueMeaning":{"publicId":"6572312","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT0 TNM Finding v8","longName":"6572312","preferredDefinition":"No evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pT0 TNM Finding v8","conceptCode":"C140914","definition":"No evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BE64-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BE7D-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"TX","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pTX TNM Finding v8","ValueMeaning":{"publicId":"6572314","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pTX TNM Finding v8","longName":"6572314","preferredDefinition":"Primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pTX TNM Finding v8","conceptCode":"C140913","definition":"Primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD16966-BE8A-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD16966-BEA3-42C3-E053-F662850ACF01","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6868015","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic (undifferentiated) thyroid carcinoma, following the rules of the TNM AJCC v8 classification system. Medullary thyroid cancers are staged according to the classification for thyroid-medullary. Thyroid lymphomas are staged according to the classification for Hodgkin and non-Hodgkin lymphoma. There are no AJCC staging systems for thyroid cancer arising from thyroglossal duct cyst and thyroid cancer in malignant struma ovarii. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140897:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma TNM Finding v8","conceptCode":"C140897","definition":"A finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic (undifferentiated) thyroid carcinoma, following the rules of the TNM AJCC v8 classification system. Medullary thyroid cancers are staged according to the classification for thyroid-medullary. Thyroid lymphomas are staged according to the classification for Hodgkin and non-Hodgkin lymphoma. There are no AJCC staging systems for thyroid cancer arising from thyroglossal duct cyst and thyroid cancer in malignant struma ovarii. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9145E052-71DD-11F2-E053-F662850A2717","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-29","modifiedBy":"ONEDATA","dateModified":"2019-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BD16966-BCCC-42C3-E053-F662850ACF01","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000440","version":"1","longName":"Thyroid","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T category","type":"Preferred Question Text","description":"Clinical T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BD41956-D481-48DC-E053-F662850A3E03","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}